Capitale Di Prestito Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 4.53B 1.95B 2024-12
Cipla INR 4.69B 874.1M 2026-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 2.94B 1.01B 2026-09
J&J USD 35.8B 1.55B 2026-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 60B 498M 2026-09
RedHill Biopharma USD 859K 41K 2026-06
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12